Posted by Michael Wonder on 20 Oct 2022
Department of Health tweaks the agenda for November 2022 PBAC meeting
19 October 2022 - Two minor changes made the day after the release of version 3.
The Department of Health has made the following minor changes to the agenda for next month's PBAC meeting:
- Glycomacropeptide with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine (PKU Sphere Liquid) – Trade name amended
- Infliximab (Remsima SC) – Drug form amended
